Abstract:Background The global coronavirus disease 2019 (COVID-19) pandemic seriously affected people's lives. We evaluated anxiety and depression among patients with insomnia in northeast China during the first wave and release of COVID-19, providing a basis for the clinical diagnosis and treatment of insomnia. Methods We enrolled 4211 patients with insomnia from January 2016 to February 2020, August 2020 to February 2022, August 2022 to December 2022, and January 2023 to February 2023, from our institution. Sleep quality was evaluated using the Athens Insomnia Scale, Insomnia Severity Index (ISI), and Pittsburgh sleep quality index (PSQI), while mood disorder and fatigue were evaluated using the Hhospital anxiety and depression scale (HAD), Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder (GAD-7), and Fatigue Scale-14 (FS-14). Results Insomnia with depression increased in prevalence after COVID-19 compared with before (12.8¬†% vs. 15.3¬†%, P ¬†<¬†0.05), while the age of patients decreased [(50.2¬†¬Ī¬†15.2) vs. (47.5¬†¬Ī¬†16.8), P ¬†<¬†0.05]. The number of patients with insomnia and severe depression increased compared with before COVID-19 (20.3¬†% vs. 25.3¬†%, P ¬† 2¬†years had depression ( P ¬†<¬†0.05). As the epidemic subsided, insomnia increased among young and male patients (young patients: 55.2¬†% vs. 37.0¬†%; male patients: 41¬†% vs. 27.4¬†%, respectively; P ¬†<¬†0.05). The proportion of patients with insomnia with anxiety and depression increased (53.8¬†% vs. 51.8¬†%, P ¬†<¬†0.05), the proportion with moderate to severe anxiety increased (7.6¬†% vs. 13.5¬†%, P ¬†<¬†0.05), and moderate and severe depression decreased (moderate: 25.6¬†% vs. 19.1¬†%, severe: 25.8¬†% vs. 20.3¬†%, P ¬†<¬†0.05, respectively). Middle-aged and elderly patients had higher PQSI scores in sleep latency, habitual sleep efficiency, subjective sleep quality, and use of sleep medications than young patients ( P ¬†<¬†0.05). The PSQI score was positively correlated with the PHQ-9 score ( r ¬†=¬†0.526), GAD-7 score ( r ¬†=¬†0.563), and FS-14 score ( r ¬†=¬†0.316) ( P ¬†<¬†0.05). Limitations The study was single-center, the sample size was small, and assessment data were lacking from early in the epidemic. The scale is subjective, which may affect the accuracy. Conclusion Insomnia with depression increased during COVID-19. The patients were younger than before the epidemic, and a higher proportion with insomnia for >2¬†years had depression. The proportion of patients with insomnia with anxiety and depression was higher after the epidemic period, and the degree worsened. The proportion of insomnia with depression decreased after the epidemic period, and the degree alleviated. The proportion of young male patients with insomnia increased. Middle aged and elderly patients with insomnia had poor sleep quality, which was positively correlated with anxiety, depression, and fatigue.

Network analysis of comorbid insomnia and depressive symptoms among psychiatric practitioners during the COVID-19 pandemic

Network analysis of depression, anxiety, insomnia and quality of life among Macau residents during the COVID-19 pandemic

Network Analysis of Depression, Anxiety, Posttraumatic Stress Symptoms, Insomnia, Pain, and Fatigue in Clinically Stable Older Patients With Psychiatric Disorders During the COVID-19 Outbreak

Prevalence and network structure of depression, insomnia and suicidality among mental health professionals who recovered from COVID-19: a national survey in China

Prevalence of insomnia and its association with quality of life in caregivers of psychiatric inpatients during the COVID-19 pandemic: a network analysis

Network Analysis of Comorbid Depression and Anxiety and Their Associations with Quality of Life among Clinicians in Public Hospitals During the Late Stage of the COVID-19 Pandemic in China

Night shifts, insomnia, anxiety, and depression among Chinese nurses during the COVID-19 pandemic remission period: A network approach

A Network Analysis of Anxiety and Depression Symptoms among Chinese Nurses in the Late Stage of the COVID-19 Pandemic

Seeking bridge symptoms of anxiety, depression, and sleep disturbance among the elderly during the lockdown of the COVID-19 pandemic—A network approach

Insomnia, Anxiety, and Depression During the COVID-19 Pandemic: an International Collaborative Study

Network Analysis of Depressive Symptoms Among Residents of Wuhan in the Later Stage of the COVID-19 Pandemic

Comorbidity of anxiety and depression disorder among clinical referral patients: a longitudinal study based on network analysis

Depression, anxiety, and insomnia symptoms among Chinese college students: A network analysis across pandemic stages

Prevalence of insomnia and its association with quality of life among Macau residents shortly after the summer 2022 COVID-19 outbreak: A network analysis perspective

Anxiety and depression among patients with insomnia during the first wave and the release of the COVID-19 in Northeast China: A cross-sectional survey

Network structure of insomnia and depressive symptoms among shift workers in China

Centrality and bridge symptoms of anxiety, depression, and sleep disturbance among college students during the COVID-19 pandemic—a network analysis

Status and influential factors of anxiety depression and insomnia symptoms in the work resumption period of COVID-19 epidemic: A multicenter cross-sectional study

Network Analysis of Depressive Symptoms in Hong Kong Residents During the COVID-19 Pandemic.

A network analysis of the interrelationships between depression, anxiety, insomnia and quality of life among fire service recruits

Network Analysis of Anxiety and Depressive Symptoms among Nursing Students During the COVID-19 Pandemic.